Thank you to our Foundational and Sustaining members
Pear Therapeutics Launches Pear Prescription Digital Therapeutics Digest, Provides Roadmap for Payer Coverage Considerations Pear Therapeutics is the leader in developing and commercializing prescription digital therapeutics (PDTs) to treat serious disease, with three FDA-authorized PDTs Inaugural edition of the Digest explores employer and payer stakeholder knowledge of PDTs as well as current considerations and perceptions […]
Boston, October 19, 2021 – Pear Therapeutics, Inc., in collaboration with Avalere Health, an Inovalon company, today launched the Pear Prescription Digital Therapeutics Digest (Pear PDT Digest) at the Academy of Managed Care Pharmacy’s (AMCP) 2021 Nexus conference. The Digest was presented during the Partner Session “Pioneering Prescription Digital Therapeutics to Transform the U.S. Health Care System,” and outlines findings from […]
Give us Pear Therapeutics’ elevator pitch. At Pear, we are creating Prescription Digital Therapeutics (PDTs), the next generation of therapeutics that use software to directly treat serious disease, alone or in combination with drugs, allowing for optimized, remote care at scale. We sit at the nexus of biotech, tech and medical device, with the aim to redefine […]